Role of Necroptosis, a Regulated Cell Death, in Seizure and Epilepsy

• Published in: Neurochemical research 2024, Vol.49 (1), p.1-13
• Main Authors: Mohseni-Moghaddam, Parvaneh, Khaleghzadeh-Ahangar, Hossein, Atabaki, Rabi
• Format: Article
• Language: English
• Subjects: Adenosine triphosphate; Amygdala; Astrocytes; ATP; Biochemistry; Biomedical and Life Sciences; Biomedicine; Calcium ions; Calpain; Caspase-8; Cell Biology; Cell death; Central nervous system; Convulsions & seizures; Cortex (piriform); Dentate gyrus; Dimerization; Epilepsy; Inflammation; Kinases; Literature reviews; MAP kinase; Mortality; Necroptosis; Neurochemistry; Neurodegenerative diseases; Neurological diseases; Neurology; Neurosciences; Oxidative stress; Potassium; Proteins; Review; Seizures; Therapeutic targets; Tumor necrosis factor-α
• ISSN: 0364-3190; 1573-6903
• DOI: 10.1007/s11064-023-04010-x

Epilepsy is a chronic neurological disease that is characterized by spontaneous and recurrent seizures. Regulated cell death is a controlled process and has been shown to be involved in neurodegenerative diseases. Necroptosis is a type of regulated cell death, and its association with epilepsy has been documented. Necroptosis signaling can be divided into two pathways: canonical and non-canonical pathways. Inhibition of caspase-8, dimerization of receptor-interacting protein kinase 1 (RIP1) and RIP3, activation of mixed-lineage kinase domain-like protein (MLKL), movement of MLKL to the plasma membrane, and cell rupture occurred in these pathways. Through literature review, it has been revealed that there is a relationship between seizure, neuroinflammation, and oxidative stress. The seizure activity triggers the activation of various pathways within the central nervous system, including TNF-α/matrix metalloproteases, Neogenin and Calpain/ Jun N-terminal Kinase 1, which result in distinct responses in the brain. These responses involve the activation of neurons and astrocytes, consequently leading to an increase in the expression levels of proteins and genes such as RIP1, RIP3, and MLKL in a time-dependent manner in regions such as the hippocampus (CA1, CA3, dentate gyrus, and hilus), piriform cortex, and amygdala. Furthermore, the imbalance in calcium ions, depletion of adenosine triphosphate, and elevation of extracellular glutamate and potassium within these pathways lead to the progression of necroptosis, a reduction in seizure threshold, and increased susceptibility to epilepsy. Therefore, it is plausible that therapeutic targeting of these pathways could potentially provide a promising approach for managing seizures and epilepsy.